Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 10;8(1):e906.
doi: 10.1212/NXI.0000000000000906. Print 2021 Jan.

Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS

Affiliations

Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS

Ruth Schneider et al. Neurol Neuroimmunol Neuroinflamm. .

Abstract

Objective: To investigate cross-sectional associations of CSF levels of neurofilament light chain (NfL) and of the newly emerging marker chitinase 3-like protein 1 (CHI3L1) with brain and spinal cord atrophy, which are established MRI markers of disease activity in MS, to study CHI3L1 and NfL in relapsing (RMS) and progressive MS (PMS), and to assess the expression of CHI3L1 in different cell types.

Methods: In a single-center study, 131 patients with MS (42 RMS and 89 PMS) were assessed for NfL and CHI3L1 concentrations in CSF, MRI-based spinal cord and brain volumetry, MS subtype, age, disease duration, and disability. We included 42 matched healthy controls receiving MRI. CHI3L1 expression of human brain cell types was examined in 2 published single-cell RNA sequencing data sets.

Results: CHI3L1 was associated with spinal cord volume (B = -1.07, 95% CI -2.04 to -0.11, p = 0.029) but not with brain volumes. NfL was associated with brain gray matter (B = -7.3, 95% CI -12.0 to -2.7, p = 0.003) but not with spinal cord volume. CHI3L1 was suitable to differentiate between progressive or relapsing MS (p = 0.015, OR 1.0103, CI for OR 1.002-1.0187), and its gene expression was found in MS-associated microglia and macrophages and in astrocytes of MS brains.

Conclusions: NfL and CHI3L1 in CSF were differentially related to brain and spinal cord atrophy. CSF CHI3L1 was associated with spinal cord volume loss and was less affected than NfL by disease duration and age, whereas CSF NfL was associated with brain gray matter atrophy. CSF NfL and CHI3L1 measurement provides complementary information regarding brain and spinal cord volumes.

Classification of evidence: This study provides Class II evidence that CSF CHI3L1 is associated with spinal cord volume loss and that CSF NfL is associated with gray matter atrophy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. CHI3L1 (A) and NfL (B) concentrations in CSF of PMS and RMS
The 2D plots depict the distribution of the results; the boxes mark the median and interquartile ranges. The 2D plots depict the distribution of the results; the boxes mark the median and interquartile ranges. *p < 0.050, **p < 0.001 in Mann-Whitney U tests. CHI3L1 = chitinase 3–like protein 1; NfL = neurofilament light chain; PMS = progressive MS; RMS = relapsing MS.
Figure 2
Figure 2. Association between (A) CHI3L1 and MUCCA and (B) NfL and BGM
The line represents simple linear regressions between the variable pairs with R2: coefficient of determination. BGM = brain gray matter; CHI3L1 = chitinase 3–like protein 1; NfL = neurofilament light chain; MUCCA = mean upper cervical cord area.

Similar articles

Cited by

References

    1. Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 2013;19:309–319. - PubMed
    1. Teunissen CE, Khalil M. Neurofilaments as biomarkers in multiple sclerosis. Mult Scler 2012;18:552–556. - PubMed
    1. Kuhle J, Plavina T, Barro C, et al. . Neurofilament light levels are associated with long-term outcomes in multiple sclerosis. Mult Scler Epub 2019 Nov 4. - PMC - PubMed
    1. Håkansson I, Tisell A, Cassel P, et al. . Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis. Eur J Neurol 2017;24:703–712. - PubMed
    1. Arrambide G, Espejo C, Eixarch H, et al. . Neurofilament light chain level is a weak risk factor for the development of MS. Neurology 2016;87:1076–1084. - PMC - PubMed

Publication types

MeSH terms